Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,280.00
-10.00 (-0.78%)
Aug 5, 2025, 4:46 PM IDT
Golden House Revenue
Golden House had revenue of 11.26M ILS in the quarter ending March 31, 2025, with 14.85% growth. This brings the company's revenue in the last twelve months to 41.28M, down -17.99% year-over-year. In the year 2024, Golden House had annual revenue of 39.82M, down -26.66%.
Revenue (ttm)
41.28M
Revenue Growth
-17.99%
P/S Ratio
4.83
Revenue / Employee
355.83K
Employees
116
Market Cap
199.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.82M | -14.48M | -26.66% |
| Dec 31, 2023 | 54.30M | -1.68M | -3.00% |
| Dec 31, 2022 | 55.97M | -237.00K | -0.42% |
| Dec 31, 2021 | 56.21M | -3.80M | -6.33% |
| Dec 31, 2020 | 60.01M | 3.40M | 6.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.81B |
| Kamada | 622.70M |
| Bait Bakfar | 104.50M |
| SofWave Medical | 235.09M |
| BrainsWay | 161.81M |
| Novolog (Pharm-Up 1966) | 2.07B |
| Ilex Medical | 922.08M |